SuperworthiRhythm profit margin IRTC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2015.
- Net margin, 12 months
- −1.7%
- Operating margin, 12 months
- −3.0%
- Net margin on a year earlier
- +12.4 pts
- Peer median
- 8.2%
Over the twelve months to Jun 30, 2026, iRhythm kept −1.7% of its revenue as net profit, with an operating margin of −3.0% and a gross margin of 71.5%.
Five years earlier its net margin was −19.4%.
The median for 10 medical instruments and supplies stocks of a similar size is 8.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −6.0% | −7.7% | 70.6% |
| FY2024 | −19.1% | −19.5% | 68.9% |
| FY2023 | −25.0% | −25.4% | 67.3% |
| FY2022 | −28.3% | −27.7% | 68.5% |
| FY2021 | −31.4% | −31.0% | 66.2% |
| FY2020 | −16.5% | −16.5% | 73.5% |
| FY2019 | −25.4% | −25.5% | 75.5% |
| FY2018 | −34.2% | −31.0% | 73.7% |
| FY2017 | −29.9% | −27.7% | 71.9% |
| FY2016 | −32.6% | −24.3% | 67.4% |
| FY2015 | −63.1% | n/a | 59.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −1.7% | +12.4 pts | −3.0% | |
| Q1 FY26 | −3.5% | +12.4 pts | −5.2% | |
| Q4 FY25 | −6.0% | +13.2 pts | −7.7% | |
| Q3 FY25 | −7.3% | +19.6 pts | −9.1% | |
| Q2 FY25 | −14.1% | +10.4 pts | −16.1% | |
| Q1 FY25 | −15.9% | +9.4 pts | −17.8% | |
| Q4 FY24 | −19.1% | +5.9 pts | −19.5% | |
| Q3 FY24 | −26.9% | −4.7 pts | −26.9% | |
| Q2 FY24 | −24.5% | −2.5 pts | −23.8% | |
| Q1 FY24 | −25.3% | −1.0 pts | −24.1% | |
| Q4 FY23 | −25.0% | +3.2 pts | −25.4% | |
| Q3 FY23 | −22.2% | +11.6 pts | −22.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest iRhythm's size, closest first, today.
| Company | Profit margin |
|---|---|
| IRTCiRhythm | −1.7% |
| ICUIICU Medical | 1.4% |
| NVSTEnvista | 3.3% |
| BMIBadger Meter | 14.3% |
| VNTVontier | 11.3% |
| WRBYWarby Parker | 0.8% |
| ATRCAtriCure | 1.9% |
| HAEHaemonetics | 7.1% |
| MMSIMerit Medical Systems | 9.2% |
| UFPTUFP Technologies | 11.4% |
| MSAMSA Safety | 16.1% |
| Peer median | 8.2% |
Where iRhythm ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on iRhythm
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.